Cognis Nutrition & Health Focuses on Customer Partnerships for Condition-Specific Formulations

06-Oct-2003

Cognis Nutrition & Health, a global leader in concept-driven customer solutions and natural ingredients for the dietary supplement and food industries, announced that it is launching a new initiative in partnership with its customers to create condition-specific formulations. Cognis is also enhancing its customer-driven programs with an expanded product line and plans to further grow the business through acquisitions and partnerships to provide continued added value to its customers.

Four main health sectors comprise the focus of Cognis' new approach to condition-specific formulations: heart health, body composition, cognitive function and eye health. These areas were designated based on customer feedback, market research and science.

One of Cognis' new condition-specific products includes a carotenoid blend targeted at maintaining eye health and prostate health in addition to providing a safe source of vitamin A. Another focus for Cognis' carotenoid product is bridging the food gap created by diets low in important antioxidants. This new blend will provide manufacturers and marketers with the industry's only "natural package" of key carotenoids for their formulations.

To anticipate long-term demand for health-enhancing products, Cognis is expanding its portfolio with safe, science-backed products of natural origin. "We believe the 'natural platform' for Cognis' product development, backed by our extensive scientific and marketing support, distinguishes our business," said Paul Allen, Group Vice President, Cognis Nutrition & Health. "The industry has grown dramatically since Cognis began producing our first vitamin E products in 1967. Now, decades later, Cognis must continue to develop products and concepts that generate sustainable added value for our customers in key market segments worldwide," Mr. Allen added.

This strategic approach is working as evidenced by recent additions to the Cognis Nutrition & Health product portfolio. The latest product to join the Cognis family is TONALIN® CLA, a natural source of conjugated linoleic acid and the No. 1 selling brand of CLA worldwide. Cognis' exclusive license for TONALIN® CLA provides brand rights for key markets in dietary supplements and food based on the primary health claim that it helps reduce body fat while maintaining or increasing lean body mass. Mr. Allen pointed out that Cognis will continue to strengthen TONALIN® CLA's brand equity in established markets, develop opportunities in new ones, and promote and support credible research on CLA's several promising health applications.

https://www.chemeurope.com/en/news/29275/cognis-nutrition-health-focuses-on-customer-partnerships-for-condition-specific-formulations.html